Publications by authors named "L Urso"

The final disposal of NORM wastes in conventional landfill generally determines problems of acceptance by the landfill operators, since their willingness to accept Naturally Occurring Radioactive Material (NORM) is often limited due to their concern about the radiological risks and reluctance of the local community to have at local landfills material that despite being cleared is still perceived as 'radioactive'. In order to raise awareness among landfill operators, and also among other stakeholders on the actual radiological risk of exempted or cleared NORM wastes, it is of interest to estimate the mass of annual wastes containing NORM that can be disposed of in a landfill for conventional waste complying with the annual dose criterion of 1 mSv. A methodology was developed considering a hypothetical homogeneous large landfill and assuming that NORM wastes are delivered with an initial activity concentration of 1 kBq kg.

View Article and Find Full Text PDF
Article Synopsis
  • The approval of radioligand therapy (RLT) by EMA in 2017 and FDA in 2018 has led to its broader use in treating neuroendocrine neoplasms (NENs), particularly advanced well-differentiated gastro-entero-pancreatic types.
  • However, RLT applications are limited to specific tumor types, leaving some tumors, like those from the sympathetic-adrenal-medullary (SAM) axis, as "RLT-orphans" that cannot currently benefit from this therapy.
  • The paper explores theragnostic options for treating pheochromocytomas and paragangliomas, discussing traditional methods with MIBG and potential future applications using radiolabeled somat
View Article and Find Full Text PDF

A 73-year-old male with left hip prosthesis infection performed a Tc HMPAO-labelled autologous WBC (WBC) scan to evaluate the response to antibiotic therapy. Since the early planar scan, an area of increased activity was visible extending from the left groin region to the ipsilateral flank. At late planar images, the area progressively focused in the left groin, site of a painful inguinal hernia.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the use of FAPI PET/CT imaging in various urological cancers, particularly prostate, urothelial, and renal cell carcinomas.
  • Preliminary findings suggest FAPI PET can detect primary prostate cancer even with low prostate-specific membrane antigen expression, although it is less effective than prostate-specific membrane antigen PET/CT for spotting recurrence.
  • FAPI PET/CT shows improved detection rates for small lymph node metastases in urothelial carcinoma compared to traditional imaging, highlighting its potential, especially for bladder cancer, but more research is needed to fully understand its clinical applications.
View Article and Find Full Text PDF